GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Taxane-induced peripheral neuropathy (TIPN) caused by albumin-bound paclitaxel is a
dose-limiting toxicity. The main symptoms of discomfort are numbness, tingling, and burning
sensations in the glove-sock-like distribution of the limbs. At present, there are few
effective methods for clinical treatment of TIPN, and there is no widely agreed consensus on
effective treatment in the world. Therefore, it is of great clinical significance and
practical value to carry out clinical research to explore drugs to relieve TIPN.